Richard Flavell
About Richard Flavell
Richard Flavell is an Investigator and Sterling Professor at HHMI/Yale University, where he has worked since 1988. He previously served as Chief Scientific Officer at Biogen from 1982 to 1988 and as Chairman at HHMI/Yale University from 1988 to 2016.
Work at Yale University
Richard Flavell has been an Investigator and Sterling Professor at Yale University since 1988. His role at Yale has spanned over 36 years, during which he has contributed significantly to the research community. Flavell's work at Yale is associated with the Howard Hughes Medical Institute (HHMI), where he continues to engage in innovative research initiatives.
Previous Experience at Biogen
Before joining Yale University, Richard Flavell served as Chief Scientific Officer (CSO) at Biogen from 1982 to 1988. His tenure at Biogen lasted six years, during which he played a key role in advancing the company's scientific agenda and research capabilities.
Leadership Role at HHMI/Yale University
Richard Flavell held the position of Chairman at HHMI/Yale University from 1988 to 2016. This leadership role lasted for 28 years and involved overseeing various research initiatives and guiding the direction of scientific inquiry within the institution.
Research Focus and Contributions
Throughout his career, Richard Flavell has focused on various aspects of biomedical research. His work has been instrumental in advancing understanding in his field, contributing to the body of knowledge that informs contemporary scientific practices.